Gemmily — Medicare Part D Spending

Generic: Norethindrone-E.Estradiol-Iron | Manufacturer: Overall

2023 Spending

$11.5K

2023 Claims

2023 Beneficiaries

Cost/Unit (2023)

$3.10

5-Year Spending Trend (2019-2023)

Year	Total Spending	Claims	Beneficiaries	Cost/Unit
2019	N/A	N/A	N/A	N/A
2020	N/A	N/A	N/A	N/A
2021	$15.1K	77	23	$4.33
2022	$18.8K	86	26	$4.51
2023	$11.5K	70	24	$3.10

5Y CAGR (cost/unit): -15.3%YoY Change (2022-2023): -31.2%

Spending by State

State	Total Drug Cost	Claims	Prescribers	Beneficiaries
Delaware	$1.6K	13	1	N/A

📊

DrugPricePeek Editorial TeamData Specialists

The DrugPricePeek editorial team aggregates and verifies drugs data from CMS NADAC & Medicare Part D. Every statistic on this site is cross-referenced against the official source before publication, with quarterly re-verification cycles.

✓ Sourced from CMS NADAC & Medicare Part D✓ Quarterly review✓ No paid placements

Read our full methodology or contact us with corrections.

Frequently Asked Questions

How much does Medicare spend on Gemmily?

In 2023, Medicare Part D spent $11.5K on Gemmily (Norethindrone-E.Estradiol-Iron), serving 24 beneficiaries across 70 claims.

What is the cost per unit of Gemmily under Medicare?

The weighted average cost per dosage unit of Gemmily was $3.10 in 2023. The 5-year compound annual growth rate (2019-2023) was -15.3%.

Who manufactures Gemmily?

Gemmily (generic name: Norethindrone-E.Estradiol-Iron) is manufactured by Overall. There are 1 manufacturer(s) listed in the CMS database for this drug.

Is Gemmily covered by Medicare Part D?

Yes, Gemmily is included in Medicare Part D spending data, indicating it is covered by Part D plans. However, specific coverage and tier placement vary by plan. Check with your specific Part D plan for formulary details.

Where does this Medicare spending data come from?

All Medicare Part D spending data comes from the Centers for Medicare & Medicaid Services (CMS) Medicare Part D Spending by Drug dataset, which is publicly available at data.cms.gov.

Explore More Data Tools

For adjacent public-data tools, methodology notes, and network updates, visit DataPeek Facts.

Year

Total Spending

Claims

Beneficiaries

Cost/Unit

2019

N/A

2020

N/A

2021

$15.1K

$4.33

2022

$18.8K

$4.51

2023